William Creasman to Uterine Cervical Dysplasia
This is a "connection" page, showing publications William Creasman has written about Uterine Cervical Dysplasia.
Connection Strength
0.801
-
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.
Score: 0.250
-
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
Score: 0.221
-
Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. Gynecol Oncol. 1994 Nov; 55(2):313-7.
Score: 0.118
-
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
Score: 0.068
-
Cryotherapy in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 1983 Sep; 62(3):353-8.
Score: 0.054
-
Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol. 2001 Jan; 184(2):64-9.
Score: 0.045
-
Evaluation of the atypical Pap smear. Am J Obstet Gynecol. 1987 Sep; 157(3):544-9.
Score: 0.018
-
Results of outpatient therapy of cervical intraepithelial neoplasia. Gynecol Oncol. 1981 Oct; 12(2 Pt 2):S306-16.
Score: 0.012
-
The abnormal Pap smear--what to do next? Cancer. 1981 Jul 15; 48(2 Suppl):515-22.
Score: 0.012
-
Cytopathology and the management of early invasive cancer of the uterine cervix. Obstet Gynecol. 1982 Sep; 60(3):350-3.
Score: 0.003